healthcare · HIPAA · FDA SaMD guidance · EU AI Act Annex III
Digital Pathology AI
Digital Pathology AI — AI decision audit trail required for liability defense
—FADP revised + FINMA AI expectations
Regulatory exposure — commonly overlooked:
Niche Digital Pathology AI deployer owns AI harm — vertical SaaS vendor owns liability cap. · Swiss reinsurance hub — Munich Re, Swiss Re need asymmetry data with Swiss privacy compliance.
TAM / Exposure
Global Digital Pathology AI market
Insurance lines
E&O · Cyber · Sector liability
Exhibit authority
Switzerland FINMA AI Pack — Digital Pathology AI External Validation Pack
Global leaders
Sector regulators · Vertical SaaS platforms · FINMA · Swiss Re · Munich Re · UBS
Niche litigation
Digital Pathology AI plaintiffs challenge AI decision without independent verify.
Insurance bind
Sector insurers asking AI governance questions on Digital Pathology AI accounts.
[Switzerland] Reinsurance capital
Geneva/Zurich reinsurers price AI risk — actuarial feed jurisdiction-scoped.
[Switzerland] Banking secrecy
Swiss bank AI — FINMA documentation expectations exceed EU for trading AI.
[Text / Chat] Modality hook
Baseline — all frameworks apply to text decisions.
7 mandate layers (live)
Regulatory ClockCountdown to operative regulatory deadline — NAIC adoption, GSE mandate, EU transposition.Open →
Domain ClassifierIndustry-specific SAFE/CRISIS/VIOLATION with regulatory framework mapping.Open →
Exhibit / Filing PackRegulator-ready external validation — NAIC Exhibit D, Fannie QC, EU FRIA, FDA Part 11.Open →
Mandate RegistryEnroll deployers/insureds under vertical-specific governance mandate.Open →